| ［1］ |
Buchheit KM, Bernstein JA. Progestogen hypersensitivity: hetero⁃geneous manifestations with a common trigger［J］. J Allergy Clin Immunol Pract, 2017,5（3）:566⁃574. doi: 10.1016/j.jaip.2017.01. 019. <br />
|
| ［2］ |
Hughes GC. Progesterone and autoimmune disease［J］. Autoimmun Rev, 2012,11（6⁃7）:A502⁃A514. doi: 10.1016/j.autrev.2011.12.003.<br />
|
| ［3］ |
Tan IJ, Peeva E, Zandman⁃Goddard G. Hormonal modulation of the immune system a spotlight on the role of progestogens［J］. Autoimmun Rev, 2015,14（6）:536⁃542. doi: 10.1016/j.autrev.2015. 02.004.<br />
|
| ［4］ |
Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review［J］. Ann Allergy Asthma Immunol, 2003,90（5）:469⁃477. doi: 10.1016/S1081⁃1206（10）61838⁃8. <br />
|
| ［5］ |
Im S, Lee ES, Kim W, et al. Expression of progesterone receptor in human keratinocytes［J］. J Korean Med Sci, 2000,15（6）:647⁃654. doi: 10.3346/jkms.2000.15.6.647. <br />
|
| ［6］ |
Nguyen T, Razzaque AA. Autoimmune progesterone dermatitis: update and insights［J］. Autoimmun Rev, 2016,15（2）:191⁃197. doi: 10.1016/j.autrev.2015.11.003. <br />
|
| ［7］ |
Schoenmakers A, Vermorken A, Degreef H, et al. Corticosteroid or steroid allergy?［J］. Contact Dermatitis, 1992,26（3）:159⁃162. <br />
|
| ［8］ |
James T, Ghaferi J, LaFond A. The histopathologic features of autoimmune progesterone dermatitis［J］. J Cutan Pathol, 2017,44（1）:70⁃74. doi: 10.1111/cup.12848. <br />
|
| ［9］ |
Hill JL, Carr TF. Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol［J］. J Allergy Clin Immunol Pract, 2013,1（5）:537⁃538. doi: 10.1016/j.jaip.2013.06.005. <br />
|
| ［10］ |
Wojnarowska F, Greaves MW, Peachey RD, et al. Progesterone⁃induced erythema multiforme［J］. J R Soc Med, 1985,78（5）:407⁃408. doi: 10.1177/014107688507800512. <br />
|
| ［11］ |
Bourgeault E, Bujold J, Doucet ME. A rare case of oestrogen dermatitis［J］. J Cutan Med Surg, 2017,21（3）:261⁃262. doi: 10. 1177/1203475416685075. <br />
|
| ［12］ |
Bernstein IL, Bernstein DI, Lummus ZL, et al. A case of progesterone⁃induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis［J］. J Womens Health （Larchmt）, 2011,20（4）:643⁃648. doi: 10.1089/jwh.2010.2468. <br />
|
| ［13］ |
Benagiano G, Bastianelli C, Farris M. Hormonal contraception: present and future［J］. Drugs Today （Barc）, 2008,44（12）:905⁃923. doi: 10.1358/dot.2008.44.12.1299292. <br />
|
| ［14］ |
Bhavnani BR, Stanczyk FZ. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action［J］. J Steroid Biochem Mol Biol, 2014,142:16⁃29. doi: 10.1016/j.jsbmb.2013.10. 011. <br />
|
| ［15］ |
Domeyer⁃Klenske A, Robillard D, Pulvino J, et al. Gonadotropin⁃releasing hormone agonist use to guide diagnosis and treatment of autoimmune progesterone dermatitis［J］. Obstet Gynecol, 2015,125（5）:1114⁃1116. doi: 10.1097/AOG.0000000000000569. <br />
|
| ［16］ |
Cosman F. Selective estrogen⁃receptor modulators［J］. Clin Geriatr Med, 2003,19（2）:371⁃379.<br />
|
| ［17］ |
Foer D, Buchheit KM. Progestogen hypersensitivity: an evidence⁃based approach to diagnosis and management in clinical practice［J］. Immunol Allergy Clin North Am, 2017,37（4）:773⁃784. doi: 10.1016/j.iac.2017.07.006. <br />
|
| ［18］ |
Drayer SM, Laufer LR, Farrell ME. Autoimmune progesterone dermatitis presenting as Stevens⁃Johnson syndrome［J］. Obstet Gynecol, 2017,130（4）:881⁃884. doi: 10.1097/AOG.000000000000 2256. <br />
|
| ［19］ |
Foer D, Buchheit KM, Gargiulo AR, et al. Progestogen hypersensi⁃tivity in 24 cases: diagnosis, management, and proposed renaming and classification［J］. J Allergy Clin Immunol Pract, 2016,4（4）:723⁃729. doi: 10.1016/j.jaip.2016.03.003.<br />
|
